高级检索

从卫生科学证据到推荐与决策的原则

Principles for transforming health evidence to recommendations and decisions

  • 摘要: 科学筛选海量高质量的卫生科学证据、透明且可靠地转化为能指导卫生实践推荐意见并辅助卫生决策,是公共卫生领域面临的核心挑战之一,也是循证卫生的核心环节。本文介绍从卫生科学证据到推荐与决策的基本原则,围绕证据推荐分级的评估、制订与评价(Grading of Recommendations Assessment,Development and Evaluation, GRADE)工作组于2025年6月所发布的从卫生科学证据到推荐和决策的原则(简称Core GRADE 7),系统阐述从卫生证据评估到形成推荐意见全过程中的关键原则、决策框架及基本流程。本文对国际从卫生科学证据到推荐与决策的原则(Core GRADE 7)的核心内容进行解读,阐明Core GRADE 7如何通过结构化的“证据到决策”(EtD)框架,系统权衡干预措施的利弊,评估证据的确定性,并整合患者价值与偏好、卫生资源、可接受性、公平性等多维因素,最终形成有明确方向与强度的推荐意见,为我国卫生实践指南的制定者、公共卫生从业者、卫生决策者及研究者提供参考。

     

    Abstract: Systematically, transparently, and reliably translating the vast body of high-quality medical scientific evidence into recommendations that can guide clinical practice and health policy is a core challenge faced by the global medical community and a central component of evidence-based medicine. This article introduces the fundamental principles for translating health evidence into recommendations and decisions. Centering on the principles for moving from science evidence into recommendations and decisions (Core GRADE 7) released by the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group in June 2025, this article systematically elaborates on the key principles, decision-making frameworks, and critical considerations throughout the entire process from health evidence evaluation to the formulation of recommendations. By interpreting the core contents of Core GRADE 7, this article clarifies how Core GRADE 7 employs a structured Evidence-to-Decision (EtD) framework to systematically weigh the benefits and harms of interventions, assess the certainty of evidence, and integrate multidimensional factors-including patient values and preferences, health resource availability, acceptability, and equity-to ultimately form recommendations with clear directions and strengths. By doing so, this paper aims to provide a reference for developers of health practice guidelines, public health practitioners, health policymakers, researchers, and other stakeholders in China.

     

/

返回文章
返回